Terms: = Brain cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Treatment
11 results:
1. Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia.
Swinton MK; Carson A; Telese F; Sanchez AB; Soontornniyomkij B; Rad L; Batki I; Quintanilla B; Pérez-Santiago J; Achim CL; Letendre S; Ellis RJ; Grant I; Murphy AN; Fields JA
Neurobiol Dis; 2019 Oct; 130():104502. PubMed ID: 31238091
[TBL] [Abstract] [Full Text] [Related]
2. Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study.
Song H; Zhong CS; Kieran MW; Chi SN; Wright KD; Huang JT
Pediatr Blood Cancer; 2019 Jun; 66(6):e27682. PubMed ID: 30821092
[TBL] [Abstract] [Full Text] [Related]
3. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract] [Full Text] [Related]
4. The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human cancer Cell Lines.
Müller L; Radtke A; Decker J; Koch M; Belge G
Anticancer Res; 2017 Nov; 37(11):6341-6345. PubMed ID: 29061818
[TBL] [Abstract] [Full Text] [Related]
5. On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines.
Ortega A; Rangel-López E; Hidalgo-Miranda A; Morales A; Ruiz-García E; Meneses-García A; Herrera-Gómez A; Aguilar-Ponce JL; González-Herrera IG; Guevara-Salazar P; Prospero-García O; Del Angel SA
Toxicol In Vitro; 2015 Oct; 29(7):1941-51. PubMed ID: 26255146
[TBL] [Abstract] [Full Text] [Related]
6. A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone.
Huttenlocher S; Dziggel L; Hornung D; Blanck O; Schild SE; Rades D
Radiat Oncol; 2014 Sep; 9():215. PubMed ID: 25240823
[TBL] [Abstract] [Full Text] [Related]
7. Radiosurgery alone for 1-3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes.
Rades D; Sehmisch L; Huttenlocher S; Blank O; Hornung D; Terheyden P; Gliemroth J; Schild SE
Anticancer Res; 2014 Sep; 34(9):5079-82. PubMed ID: 25202094
[TBL] [Abstract] [Full Text] [Related]
8. Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis.
Segal-Lieberman G; Rubinfeld H; Glick M; Kronfeld-Schor N; Shimon I
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E982-8. PubMed ID: 16603725
[TBL] [Abstract] [Full Text] [Related]
9. Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.
McAllister SD; Chan C; Taft RJ; Luu T; Abood ME; Moore DH; Aldape K; Yount G
J Neurooncol; 2005 Aug; 74(1):31-40. PubMed ID: 16078104
[TBL] [Abstract] [Full Text] [Related]
10. Quality control of low dose craniospinal irradiation for low risk medulloblastoma.
Benk V; Bouhnik H; Raquin MA; Kalifa C; Habrand JL
Br J Radiol; 1995 Sep; 68(813):1009-13. PubMed ID: 7496681
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract] [Full Text] [Related]
